董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Brian C. Evanko | 男 | Chief Operating Officer and President and Chief Executive Officer and Director | 49 | 999.84万美元 | 16.70 | 2026-12-31 |
| Kathleen M. Mazzarella | 女 | Director | 66 | 36.03万美元 | 0.61 | 2026-12-31 |
| Mark B. McClellan | 男 | Director | 62 | 33.53万美元 | 0.61 | 2026-12-31 |
| Kimberly A. Ross | 女 | Director | 60 | 36.28万美元 | 0.45 | 2026-12-31 |
| Neesha Hathi | 女 | Director | 52 | 33.78万美元 | 0.34 | 2026-12-31 |
| Philip Ozuah | 男 | Director | 63 | 33.53万美元 | 0.18 | 2026-12-31 |
| David M. Cordani | 男 | Executive Chair of the Board | 60 | 2286.61万美元 | 120.40 | 2026-12-31 |
| Eric C. Wiseman | 男 | Lead Independent Director | 70 | 41.03万美元 | 0.47 | 2026-12-31 |
| Eric J. Foss | 男 | Director | 67 | 36.03万美元 | 3.53 | 2026-12-31 |
| Michael J. Hennigan | 男 | Director | 66 | 23.95万美元 | 0.06 | 2026-12-31 |
| George Kurian | 男 | Director | 59 | 33.53万美元 | 0.38 | 2026-12-31 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Brian C. Evanko | 男 | Chief Operating Officer and President and Chief Executive Officer and Director | 49 | 999.84万美元 | 16.70 | 2026-12-31 |
| Ann M. Dennison | 女 | Chief Financial Officer and Executive Vice President | 55 | 469.15万美元 | 0.85 | 2026-12-31 |
| Everett Neville | 男 | Executive Vice President,Strategy and Business Development | 61 | 407.39万美元 | 2.03 | 2026-12-31 |
| Jamie Kates | 女 | Global Chief Accounting Officer and Senior Vice President | 46 | 未披露 | 未持股 | 2026-12-31 |
| Durga Prasad Koka | -- | Executive Vice President and Global Chief Information Officer | 52 | 未披露 | 未持股 | 2026-12-31 |
| David M. Cordani | 男 | Executive Chair of the Board | 60 | 2286.61万美元 | 120.40 | 2026-12-31 |
| Nicole S. Jones | -- | Chief Administrative Officer and Executive Vice President and General Counsel | 55 | 595.59万美元 | 10.42 | 2026-12-31 |
董事简历
中英对照 | 中文 | 英文- Brian C. Evanko
-
Brian C. Evanko，政府业务总裁，2017年11月开始； 2013年8月至2017年11月为美国个人业务总裁； 2012年9月至2013年8月，信诺全球个人健康，生命和事故业务财务总监； 2008年12月至2012年9月，信诺全球，健康，生命和事故个人首席精算师。
Brian C. Evanko was appointed Chief Executive Officer of the Company, effective July 1, 2026. He currently serves as President and Chief Operating Officer of The Cigna Group, a role he has held since March 2025. He served as Executive Vice President, Chief Financial Officer of The Cigna Group and President and Chief Executive Officer, Cigna Healthcare from January 2024 through March 2025; Executive Vice President and Chief Financial Officer of The Cigna Group from January 2021 to January 2024; President, Government Biness from November 2017 to January 2021; and President, U.S. Individual Biness from August 2013 to November 2017. Over the cse of his nearly 30 year career with The Cigna Group, Mr. Evanko has led significant biness and functional areas. Mr. Evanko has delivered strong financial and operational results and led significant change through dynamic periods with his purpose driven, performance focused leadership.Mr. Evanko played a pivotal role in shaping the Company's strategic direction, driving priorities that are further strengthening ctomer affordability, access, and experience including the Company's "Commitments to Better." Mr. Evanko has a bachelor's degree in actuarial science from Pennsylvania State University and holds the FSA (Fellow of the Society of Actuaries), MAAA (Member of the American Academy of Actuaries) and CFA (Chartered Financial Analyst) designations.In addition to his responsibilities at The Cigna Group, Mr. Evanko serves on the board of directors for TriNet, a leading provider of comprehensive human resces solutions for small and medium size binesses, as ll as The Connecticut Science Center, the state's foremost institution for science education.BS, Pennsylvania State University. - Brian C. Evanko，政府业务总裁，2017年11月开始； 2013年8月至2017年11月为美国个人业务总裁； 2012年9月至2013年8月，信诺全球个人健康，生命和事故业务财务总监； 2008年12月至2012年9月，信诺全球，健康，生命和事故个人首席精算师。
- Brian C. Evanko was appointed Chief Executive Officer of the Company, effective July 1, 2026. He currently serves as President and Chief Operating Officer of The Cigna Group, a role he has held since March 2025. He served as Executive Vice President, Chief Financial Officer of The Cigna Group and President and Chief Executive Officer, Cigna Healthcare from January 2024 through March 2025; Executive Vice President and Chief Financial Officer of The Cigna Group from January 2021 to January 2024; President, Government Biness from November 2017 to January 2021; and President, U.S. Individual Biness from August 2013 to November 2017. Over the cse of his nearly 30 year career with The Cigna Group, Mr. Evanko has led significant biness and functional areas. Mr. Evanko has delivered strong financial and operational results and led significant change through dynamic periods with his purpose driven, performance focused leadership.Mr. Evanko played a pivotal role in shaping the Company's strategic direction, driving priorities that are further strengthening ctomer affordability, access, and experience including the Company's "Commitments to Better." Mr. Evanko has a bachelor's degree in actuarial science from Pennsylvania State University and holds the FSA (Fellow of the Society of Actuaries), MAAA (Member of the American Academy of Actuaries) and CFA (Chartered Financial Analyst) designations.In addition to his responsibilities at The Cigna Group, Mr. Evanko serves on the board of directors for TriNet, a leading provider of comprehensive human resces solutions for small and medium size binesses, as ll as The Connecticut Science Center, the state's foremost institution for science education.BS, Pennsylvania State University.
- Kathleen M. Mazzarella
-
Kathleen M. Mazzarella自2013年1月起担任Graybar Electric Company, Inc.董事长。Graybar是电气，通信和数据网络产品的分销商，以及相关供应链管理和物流服务的提供商，并担任Graybar总裁兼首席执行官。自2012年6月以来。她曾于2010年12月至2012年6月担任执行副总裁兼首席运营官。Mazzarella女士于1980年1月加入Graybar，并担任越来越高的职位，包括销售和市场营销高级副总裁和高级副总裁，人力资源和战略规划。自2004年1月以来，她一直担任Graybar的董事。Mazzarella女士从2015年1月起担任圣路易斯联邦储备银行（Federal Reserve Bank of St. Louis）的董事，并从2016年4月至2019年12月担任其主席。私人公司董事会。她拥有国立路易斯大学的理学学士学位和韦伯斯特大学的工商管理硕士学位。
Kathleen M. Mazzarella has served as Chair of Graybar Electric Company, Inc. (Graybar), a North American distributor of electrical, indtrial, automation, and connectivity products and provider of related supply chain management and logistics services, since January 2013, as President and Chief Executive Officer since June 2012, and as a Director since January 2004. She is the first woman to lead Graybar since its founding in 1925.Ms. Mazzarella serves as Co Chair for Concordance First Chance Campaign and as a Board Member for Greater St. Louis, Inc. She is a 2022 recipient of the inaugural St. Louis Titan 100 and an inaugural winner of the Modern Distribution Management Women in Distribution Leadership Award in 2021.MBA, bster University;BA, National Louis University. - Kathleen M. Mazzarella自2013年1月起担任Graybar Electric Company, Inc.董事长。Graybar是电气，通信和数据网络产品的分销商，以及相关供应链管理和物流服务的提供商，并担任Graybar总裁兼首席执行官。自2012年6月以来。她曾于2010年12月至2012年6月担任执行副总裁兼首席运营官。Mazzarella女士于1980年1月加入Graybar，并担任越来越高的职位，包括销售和市场营销高级副总裁和高级副总裁，人力资源和战略规划。自2004年1月以来，她一直担任Graybar的董事。Mazzarella女士从2015年1月起担任圣路易斯联邦储备银行（Federal Reserve Bank of St. Louis）的董事，并从2016年4月至2019年12月担任其主席。私人公司董事会。她拥有国立路易斯大学的理学学士学位和韦伯斯特大学的工商管理硕士学位。
- Kathleen M. Mazzarella has served as Chair of Graybar Electric Company, Inc. (Graybar), a North American distributor of electrical, indtrial, automation, and connectivity products and provider of related supply chain management and logistics services, since January 2013, as President and Chief Executive Officer since June 2012, and as a Director since January 2004. She is the first woman to lead Graybar since its founding in 1925.Ms. Mazzarella serves as Co Chair for Concordance First Chance Campaign and as a Board Member for Greater St. Louis, Inc. She is a 2022 recipient of the inaugural St. Louis Titan 100 and an inaugural winner of the Modern Distribution Management Women in Distribution Leadership Award in 2021.MBA, bster University;BA, National Louis University.
- Mark B. McClellan
-
Mark B. McClellan于2016年1月成为Duke Robert J.Margolis，健康政策中心的首任主任和杜克大学商业、医学和政策的Margolis教授。此前，他曾在2007年至2015年担任经济研究高级研究员，并担任Brookings Institution医疗保健价值与创新倡议主任。McClellan博士在2004年至2006年期间担任美国卫生和公众服务部医疗保险和医疗补助服务中心的管理员，并在2002年至2004年期间担任美国食品和药物管理局的专员。2001年至2002年，他曾任总统经济顾问委员会成员和白宫医疗政策高级主管，1998年至2000年，他曾任财政部负责经济政策的副助理部长。McClellan博士获得德克萨斯大学文学学士学位，哈佛大学公共管理硕士和医学博士学位，麻省理工学院经济学哲学博士学位。
Mark B. McClellan became the inaugural Director of the Duke Robert J. Margolis, M.D., Institute for Health Policy and the Margolis Professor of Biness, Medicine, and Policy at Duke University in January 2016. He currently serves in vario leadership and advisory capacities for the National Academy of Medicine, and other nonprofit organizations. He also was the founding Chair of the Reagan Udall Foundation for the U.S. Food and Drug Administration (FDA). Dr. McClellan is a two time recipient of the Kenneth Arrow Award for Outstanding Research in Health Economics.Additionally, Dr. McClellan was at the center of U.S. efforts to combat the COVID 19 pandemic and co authored a road map and other publications for a comprehensive response and safe reopening. His ongoing collaborative research programs are developing policy reforms and support for resilient models of delivering better, more equitable care to address population health challenges; for more efficient development and effective e of innovative medicines, through better evidence on outcomes; and for accelerating applications of digital and AI technologies that improve health care access and affordability.PhD, Massachetts Institute of Technology;MD, Harvard MIT Division of Health Sciences and Technology;MPA, Harvard University;BA, University of Texas. - Mark B. McClellan于2016年1月成为Duke Robert J.Margolis，健康政策中心的首任主任和杜克大学商业、医学和政策的Margolis教授。此前，他曾在2007年至2015年担任经济研究高级研究员，并担任Brookings Institution医疗保健价值与创新倡议主任。McClellan博士在2004年至2006年期间担任美国卫生和公众服务部医疗保险和医疗补助服务中心的管理员，并在2002年至2004年期间担任美国食品和药物管理局的专员。2001年至2002年，他曾任总统经济顾问委员会成员和白宫医疗政策高级主管，1998年至2000年，他曾任财政部负责经济政策的副助理部长。McClellan博士获得德克萨斯大学文学学士学位，哈佛大学公共管理硕士和医学博士学位，麻省理工学院经济学哲学博士学位。
- Mark B. McClellan became the inaugural Director of the Duke Robert J. Margolis, M.D., Institute for Health Policy and the Margolis Professor of Biness, Medicine, and Policy at Duke University in January 2016. He currently serves in vario leadership and advisory capacities for the National Academy of Medicine, and other nonprofit organizations. He also was the founding Chair of the Reagan Udall Foundation for the U.S. Food and Drug Administration (FDA). Dr. McClellan is a two time recipient of the Kenneth Arrow Award for Outstanding Research in Health Economics.Additionally, Dr. McClellan was at the center of U.S. efforts to combat the COVID 19 pandemic and co authored a road map and other publications for a comprehensive response and safe reopening. His ongoing collaborative research programs are developing policy reforms and support for resilient models of delivering better, more equitable care to address population health challenges; for more efficient development and effective e of innovative medicines, through better evidence on outcomes; and for accelerating applications of digital and AI technologies that improve health care access and affordability.PhD, Massachetts Institute of Technology;MD, Harvard MIT Division of Health Sciences and Technology;MPA, Harvard University;BA, University of Texas.
- Kimberly A. Ross
-
Kimberly A. Ross于2020年3月至9月担任灵活空间解决方案公司WeWork（We Company）的首席财务官。她曾担任能源技术公司Baker Hughes Company的高级副总裁兼首席财务官，2014年9月至2017年7月，Ross女士于2011年11月至2014年9月担任Avon Products, Inc.执行副总裁兼首席财务官，Avon Products, Inc.有限公司是一家全球美容及相关产品制造商和销售商。在加入雅芳之前，2007年至2011年，Ross女士担任食品零售公司Royal Ahold N.V。的执行副总裁兼首席财务官。在此之前，Ross女士曾在Ahold担任多个高级管理职位。罗斯女士获得南佛罗里达州大学文科学士学位。
Kimberly A. Ross served as Chief Financial Officer of WeWork from March through October 2020. She served as Senior Vice President and Chief Financial Officer of Baker Hughes Company from 2014 to 2017. Ms. Ross was Executive Vice President and Chief Financial Officer of Avon Products, Inc. from 2011 to 2014. Prior to that, she served as the Executive Vice President and Chief Financial Officer of Royal Ahold N.V. from 2007 to 2011 and previously held a variety of senior management positions at Royal Ahold. - Kimberly A. Ross于2020年3月至9月担任灵活空间解决方案公司WeWork（We Company）的首席财务官。她曾担任能源技术公司Baker Hughes Company的高级副总裁兼首席财务官，2014年9月至2017年7月，Ross女士于2011年11月至2014年9月担任Avon Products, Inc.执行副总裁兼首席财务官，Avon Products, Inc.有限公司是一家全球美容及相关产品制造商和销售商。在加入雅芳之前，2007年至2011年，Ross女士担任食品零售公司Royal Ahold N.V。的执行副总裁兼首席财务官。在此之前，Ross女士曾在Ahold担任多个高级管理职位。罗斯女士获得南佛罗里达州大学文科学士学位。
- Kimberly A. Ross served as Chief Financial Officer of WeWork from March through October 2020. She served as Senior Vice President and Chief Financial Officer of Baker Hughes Company from 2014 to 2017. Ms. Ross was Executive Vice President and Chief Financial Officer of Avon Products, Inc. from 2011 to 2014. Prior to that, she served as the Executive Vice President and Chief Financial Officer of Royal Ahold N.V. from 2007 to 2011 and previously held a variety of senior management positions at Royal Ahold.
- Neesha Hathi
-
Neesha Hathi 自 2017 年起担任金融服务公司 The Charles Schwab Corporation Charles Schwab 的首席数字官。在 2016 年至 2017 年期间，她还在 Charles Schwab 担任投资者服务平台、战略和客户体验执行副总裁； 顾问服务高级副总裁； 2012 年至 2016 年担任 Schwab Performance Technologies 首席运营官； 顾问技术解决方案副总裁； 2009 年至 2012 年担任 Schwab Performance Technologies 首席运营官； 2007年至2009年战略副总裁； 2004 年至 2007 年战略总监； 2004 年担任部门管理高级经理。Hathi 女士获得了密歇根大学的理学学士学位和加利福尼亚大学的工商管理硕士学位。
Neesha Hathi has served as Head of Wealth and Advice Solutions of The Charles Schwab Corporation (Charles Schwab), a financial services company, since 2022. In July 2026, she will assume the expanded role of Managing Director, Head of Wealth Advisory, Banking and Trt Services at Charles Schwab. Over the cse of her 20+ year career with Charles Schwab, Ms. Hathi has held positions of increasing responsibility. Notably, she was Chief Digital Officer from 2017 to 2022, during which time she was responsible for digital transformation, biness innovation, and data and analytics. Prior to that role, she served as Executive Vice President of Investor Services Platforms, Strategy and Client Experience, from 2016 to 2017, and as Senior Vice President of Advisor Services and Chief Operating Officer of Schwab Performance Technologies from 2012 through 2016.Ms. Hathi serves on the Board of Advisors at the University of California, Los Angeles, Anderson School of Management, as ll as the Charles Schwab Foundation.MBA, University of California;BBA, University of Michigan. - Neesha Hathi 自 2017 年起担任金融服务公司 The Charles Schwab Corporation Charles Schwab 的首席数字官。在 2016 年至 2017 年期间，她还在 Charles Schwab 担任投资者服务平台、战略和客户体验执行副总裁； 顾问服务高级副总裁； 2012 年至 2016 年担任 Schwab Performance Technologies 首席运营官； 顾问技术解决方案副总裁； 2009 年至 2012 年担任 Schwab Performance Technologies 首席运营官； 2007年至2009年战略副总裁； 2004 年至 2007 年战略总监； 2004 年担任部门管理高级经理。Hathi 女士获得了密歇根大学的理学学士学位和加利福尼亚大学的工商管理硕士学位。
- Neesha Hathi has served as Head of Wealth and Advice Solutions of The Charles Schwab Corporation (Charles Schwab), a financial services company, since 2022. In July 2026, she will assume the expanded role of Managing Director, Head of Wealth Advisory, Banking and Trt Services at Charles Schwab. Over the cse of her 20+ year career with Charles Schwab, Ms. Hathi has held positions of increasing responsibility. Notably, she was Chief Digital Officer from 2017 to 2022, during which time she was responsible for digital transformation, biness innovation, and data and analytics. Prior to that role, she served as Executive Vice President of Investor Services Platforms, Strategy and Client Experience, from 2016 to 2017, and as Senior Vice President of Advisor Services and Chief Operating Officer of Schwab Performance Technologies from 2012 through 2016.Ms. Hathi serves on the Board of Advisors at the University of California, Los Angeles, Anderson School of Management, as ll as the Charles Schwab Foundation.MBA, University of California;BBA, University of Michigan.
- Philip Ozuah
-
Philip Ozuah 是 Montefiore Medicine 的总裁兼首席执行官，Montefiore Medicine公司是 Montefiore 卫生系统和阿尔伯特爱因斯坦医学院的伞式组织，此前曾于 2018 年至 2019 年担任总裁，并于 2012 年至 2018 年担任执行副总裁兼首席运营官蒙蒂菲奥里卫生系统。 2005 年至 2014 年期间，Ozuah 博士担任儿科系主任，自 1992 年以来一直担任阿尔伯特爱因斯坦医学院儿科、流行病学和人口健康系的教授。 Ozuah 博士获得了尼日利亚伊巴丹大学的医学博士学位、南加州大学的硕士学位和博士学位。来自内布拉斯加大学。他在阿尔伯特爱因斯坦医学院和蒙蒂菲奥里完成了儿科实习和住院医师实习，并在南加州大学医学院完成了医学教育博士后奖学金。 Ozuah 博士是 Montefiore 医院、纽约市警察基金会和联邦执法基金会的董事会成员。
Philip Ozuah Since 2019, Dr. Philip Ozuah has served as the President and CEO of Montefiore Einstein, the umbrella organization for the Albert Einstein College of Medicine and Montefiore Health System's 13 member hospitals and 300 ambulatory sites. Dr. Ozuah has spent over 30 years at Montefiore Einstein in positions of increasing responsibility, including President of Montefiore Health System from 2018 to 2019, as ll as Executive Vice President and Chief Operating Officer from 2012 to 2018. A National Institutes of Health funded researcher and award winning educator, Dr. Ozuah has also served as Professor and University Chairman of Pediatrics at Albert Einstein College of Medicine and Physician in Chief of Children's Hospital at Montefiore (CHAM).In recognition of his accomplishments, Dr. Ozuah has been repeatedly recognized by Modern Healthcare as a top physician executive in the country. He has received countless accolades for excellence in patient care, including being inducted into the Alpha Omega Alpha Honor Medical Society. Dr. Ozuah is also an active member of his local community, serving as Chairman of the New York City Police Foundation and as a trtee of the New York Botanical Garden.PhD, University of Nebraska–Lincoln;MD, University of Ibadan, Nigeria;MS, University of Southern California. - Philip Ozuah 是 Montefiore Medicine 的总裁兼首席执行官，Montefiore Medicine公司是 Montefiore 卫生系统和阿尔伯特爱因斯坦医学院的伞式组织，此前曾于 2018 年至 2019 年担任总裁，并于 2012 年至 2018 年担任执行副总裁兼首席运营官蒙蒂菲奥里卫生系统。 2005 年至 2014 年期间，Ozuah 博士担任儿科系主任，自 1992 年以来一直担任阿尔伯特爱因斯坦医学院儿科、流行病学和人口健康系的教授。 Ozuah 博士获得了尼日利亚伊巴丹大学的医学博士学位、南加州大学的硕士学位和博士学位。来自内布拉斯加大学。他在阿尔伯特爱因斯坦医学院和蒙蒂菲奥里完成了儿科实习和住院医师实习，并在南加州大学医学院完成了医学教育博士后奖学金。 Ozuah 博士是 Montefiore 医院、纽约市警察基金会和联邦执法基金会的董事会成员。
- Philip Ozuah Since 2019, Dr. Philip Ozuah has served as the President and CEO of Montefiore Einstein, the umbrella organization for the Albert Einstein College of Medicine and Montefiore Health System's 13 member hospitals and 300 ambulatory sites. Dr. Ozuah has spent over 30 years at Montefiore Einstein in positions of increasing responsibility, including President of Montefiore Health System from 2018 to 2019, as ll as Executive Vice President and Chief Operating Officer from 2012 to 2018. A National Institutes of Health funded researcher and award winning educator, Dr. Ozuah has also served as Professor and University Chairman of Pediatrics at Albert Einstein College of Medicine and Physician in Chief of Children's Hospital at Montefiore (CHAM).In recognition of his accomplishments, Dr. Ozuah has been repeatedly recognized by Modern Healthcare as a top physician executive in the country. He has received countless accolades for excellence in patient care, including being inducted into the Alpha Omega Alpha Honor Medical Society. Dr. Ozuah is also an active member of his local community, serving as Chairman of the New York City Police Foundation and as a trtee of the New York Botanical Garden.PhD, University of Nebraska–Lincoln;MD, University of Ibadan, Nigeria;MS, University of Southern California.
- David M. Cordani
-
David M. Cordani，于2022年1月被任命为董事会主席。自2009年起担任信诺集团首席执行官，自2008年起担任总裁。自1991年加入信诺集团以来，Cordani先生曾担任多个高级领导职务，包括首席运营官；信诺医疗保健总裁；客户细分和市场营销高级副总裁。在他任职期间，信诺集团已发展成为一家财富15强的全球健康公司，拥有大约1.89亿客户和患者关系，以及约72，500名员工。
David M. Cordani was appointed Chair of the Board in January 2022. He has served as the Chief Executive Officer of The Cigna Group since 2009 and President since 2008. Since joining The Cigna Group in 1991, Mr. Cordani has served in a number of senior leadership roles, including Chief Operating Officer; President, Cigna HealthCare; and Senior Vice President, Ctomer Segments and Marketing. Under his leadership, The Cigna Group has grown into a global health company with more than 185 million ctomer relationships and approximately 67,700 colleagues around the world.Mr. Cordani is active with a number of nonprofit organizations. He currently serves in vario capacities with the Achilles International Freedom Team of Wounded Veterans, among others, and oversees the David and Sherry Cordani Family Foundation, which was founded to support community health and overall ll being. Mr. Cordani has served as an Executive Committee member of America's Health Insurance Plans (AHIP) and previoly was appointed and served as Chair of the AHIP Board. With a commitment to international biness relations, Mr. Cordani also served as Chairman of the U.S. Chamber of Commerce's U.S. Korea Biness Council and on the U.S. India Biness Council Board of Directors.MBA, University of Hartford;BBA, Texas A&M University. - David M. Cordani，于2022年1月被任命为董事会主席。自2009年起担任信诺集团首席执行官，自2008年起担任总裁。自1991年加入信诺集团以来，Cordani先生曾担任多个高级领导职务，包括首席运营官；信诺医疗保健总裁；客户细分和市场营销高级副总裁。在他任职期间，信诺集团已发展成为一家财富15强的全球健康公司，拥有大约1.89亿客户和患者关系，以及约72，500名员工。
- David M. Cordani was appointed Chair of the Board in January 2022. He has served as the Chief Executive Officer of The Cigna Group since 2009 and President since 2008. Since joining The Cigna Group in 1991, Mr. Cordani has served in a number of senior leadership roles, including Chief Operating Officer; President, Cigna HealthCare; and Senior Vice President, Ctomer Segments and Marketing. Under his leadership, The Cigna Group has grown into a global health company with more than 185 million ctomer relationships and approximately 67,700 colleagues around the world.Mr. Cordani is active with a number of nonprofit organizations. He currently serves in vario capacities with the Achilles International Freedom Team of Wounded Veterans, among others, and oversees the David and Sherry Cordani Family Foundation, which was founded to support community health and overall ll being. Mr. Cordani has served as an Executive Committee member of America's Health Insurance Plans (AHIP) and previoly was appointed and served as Chair of the AHIP Board. With a commitment to international biness relations, Mr. Cordani also served as Chairman of the U.S. Chamber of Commerce's U.S. Korea Biness Council and on the U.S. India Biness Council Board of Directors.MBA, University of Hartford;BBA, Texas A&M University.
- Eric C. Wiseman
-
Eric C. Wiseman，自2022年1月起担任信诺集团首席独立董事。2008年8月至2017年10月，他担任服装和鞋类公司VF Corporation的执行主席。他曾于2008年1月至2016年12月担任VF Corporation的首席执行官，2006年至2015年6月担任总裁，2006年至2008年担任首席运营官。在此之前，怀斯曼先生曾在该公司担任多个高级管理职位。
Eric C. Wiseman has served as the Lead Independent Director of The Cigna Group since January 2022 and will serve in such capacity until April 1, 2026. He was Executive Chair of VF Corporation, an apparel and footar company, from August 2008 until October 2017. He served as VF Corporation's Chief Executive Officer from January 2008 until December 2016, President from 2006 until June 2015, and Chief Operating Officer from 2006 to 2008. Prior to that, Mr. Wiseman held a variety of senior management positions at the company.Mr. Wiseman is an active member of his community, and he also sits on the Board of Trtees for Wake Forest University and the Board of Visitors for the Wake Forest School of Biness. He also served on the American Heart Association CEO Roundtable, a leadership collaborative of CEOs exclively dedicated to improving employee and community health.BS and MBA, Wake Forest University. - Eric C. Wiseman，自2022年1月起担任信诺集团首席独立董事。2008年8月至2017年10月，他担任服装和鞋类公司VF Corporation的执行主席。他曾于2008年1月至2016年12月担任VF Corporation的首席执行官，2006年至2015年6月担任总裁，2006年至2008年担任首席运营官。在此之前，怀斯曼先生曾在该公司担任多个高级管理职位。
- Eric C. Wiseman has served as the Lead Independent Director of The Cigna Group since January 2022 and will serve in such capacity until April 1, 2026. He was Executive Chair of VF Corporation, an apparel and footar company, from August 2008 until October 2017. He served as VF Corporation's Chief Executive Officer from January 2008 until December 2016, President from 2006 until June 2015, and Chief Operating Officer from 2006 to 2008. Prior to that, Mr. Wiseman held a variety of senior management positions at the company.Mr. Wiseman is an active member of his community, and he also sits on the Board of Trtees for Wake Forest University and the Board of Visitors for the Wake Forest School of Biness. He also served on the American Heart Association CEO Roundtable, a leadership collaborative of CEOs exclively dedicated to improving employee and community health.BS and MBA, Wake Forest University.
- Eric J. Foss
-
Eric J. Foss，2012年5月任ARAMARK公司（公开上市的餐饮服务、设施管理、制服及职业装供应商）总裁、首席执行官、董事。他2010年至2011年12月担任百事饮料公司首席执行官；2008年至2010年任百事瓶装集团（Pepsi Bottling Group）董事长和首席执行官；2006年至2008年任总裁及首席执行官。他2003年就职于UDR公司（房地产投资信托公司）董事会。他目前在Cigna公司任期为2011年至2014年。
Eric J. Foss will serve as the Lead Independent Director, The Cigna Group, beginning April 1, 2026. Mr. Foss is the Chairman and Chief Executive Officer of Primo Brands Corporation, a leading branded beverage company. He first joined the organization in 2023 as a member of the Board of Primo Water (later renamed Primo Brands) and was appointed Chairman and Chief Executive Officer in November 2025. Mr. Foss has a proven track record of driving growth for global at scale companies, having previoly served as President and Chief Executive Officer of Aramark, a provider of food services, facilities management, and uniform services, starting May 2012. He also served as Aramark Chair of the Board starting in February 2015 until his retirement from Aramark in August 2019. He served as Chief Executive Officer of Pepsi Beverages Company, a beverage manufacturer, seller, and distributor and a division of PepsiCo, Inc., from 2010 until December 2011. He was the Chair and Chief Executive Officer of The Pepsi Bottling Group, Inc., from 2008 until 2010, President and Chief Executive Officer from 2006 until 2008, and Chief Operating Officer from 2005 until 2006.BS, Ball State University. - Eric J. Foss，2012年5月任ARAMARK公司（公开上市的餐饮服务、设施管理、制服及职业装供应商）总裁、首席执行官、董事。他2010年至2011年12月担任百事饮料公司首席执行官；2008年至2010年任百事瓶装集团（Pepsi Bottling Group）董事长和首席执行官；2006年至2008年任总裁及首席执行官。他2003年就职于UDR公司（房地产投资信托公司）董事会。他目前在Cigna公司任期为2011年至2014年。
- Eric J. Foss will serve as the Lead Independent Director, The Cigna Group, beginning April 1, 2026. Mr. Foss is the Chairman and Chief Executive Officer of Primo Brands Corporation, a leading branded beverage company. He first joined the organization in 2023 as a member of the Board of Primo Water (later renamed Primo Brands) and was appointed Chairman and Chief Executive Officer in November 2025. Mr. Foss has a proven track record of driving growth for global at scale companies, having previoly served as President and Chief Executive Officer of Aramark, a provider of food services, facilities management, and uniform services, starting May 2012. He also served as Aramark Chair of the Board starting in February 2015 until his retirement from Aramark in August 2019. He served as Chief Executive Officer of Pepsi Beverages Company, a beverage manufacturer, seller, and distributor and a division of PepsiCo, Inc., from 2010 until December 2011. He was the Chair and Chief Executive Officer of The Pepsi Bottling Group, Inc., from 2008 until 2010, President and Chief Executive Officer from 2006 until 2008, and Chief Operating Officer from 2005 until 2006.BS, Ball State University.
- Michael J. Hennigan
-
Michael J. Hennigan，担任Marathon Petroleum Corporation执行主席（自2024年8月起），此前曾担任首席执行官（2020-2024年）和总裁（2020-2023年）等职务。他曾是MPLX的董事长兼首席执行官（2019-2024年），并曾在能源转换合伙人（2017年）和太阳石油 Logistics Partners（2012-2017年）担任高管职务。他目前在MPLX GP LLC和Nutrien Ltd. Hennigan的董事会任职。
Michael J. Hennigan served as the Executive Chairman of Marathon Petroleum Corporation (MPC), an integrated downstream energy company, and MPLX, a diversified master limited partnership formed by MPC from August 2024 until December 2025. He joined the company in 2017 and served as President and CEO of MPC and MPLX from March 2020 until August 2024, as President and CEO of MPLX GP LLC from November 2019 until November 2024, and President of MPLX GP LLC from July 2017 until November 2019. Prior to joining MPLX, Mr. Hennigan was President of Crude, NGL, and Refined Products of the general partner of Energy Transfer Partners L.P. Mr. Hennigan began his career at Sunoco, Inc., and spent more than three decades advancing through roles, ultimately becoming President and Chief Executive Officer of Sunoco Logistics.Mr. Hennigan served as Chairman of the American Fuels and Petrochemical Manufacturers (AFPM) association, on the Executive Committee of the American Petroleum Institute (API), and as a member of the Biness Council and the Ohio Biness Roundtable.BS, Drexel University. - Michael J. Hennigan，担任Marathon Petroleum Corporation执行主席（自2024年8月起），此前曾担任首席执行官（2020-2024年）和总裁（2020-2023年）等职务。他曾是MPLX的董事长兼首席执行官（2019-2024年），并曾在能源转换合伙人（2017年）和太阳石油 Logistics Partners（2012-2017年）担任高管职务。他目前在MPLX GP LLC和Nutrien Ltd. Hennigan的董事会任职。
- Michael J. Hennigan served as the Executive Chairman of Marathon Petroleum Corporation (MPC), an integrated downstream energy company, and MPLX, a diversified master limited partnership formed by MPC from August 2024 until December 2025. He joined the company in 2017 and served as President and CEO of MPC and MPLX from March 2020 until August 2024, as President and CEO of MPLX GP LLC from November 2019 until November 2024, and President of MPLX GP LLC from July 2017 until November 2019. Prior to joining MPLX, Mr. Hennigan was President of Crude, NGL, and Refined Products of the general partner of Energy Transfer Partners L.P. Mr. Hennigan began his career at Sunoco, Inc., and spent more than three decades advancing through roles, ultimately becoming President and Chief Executive Officer of Sunoco Logistics.Mr. Hennigan served as Chairman of the American Fuels and Petrochemical Manufacturers (AFPM) association, on the Executive Committee of the American Petroleum Institute (API), and as a member of the Biness Council and the Ohio Biness Roundtable.BS, Drexel University.
- George Kurian
-
George Kurian，被任命为NetApp首席执行官，并一直担任董事会成员，自2015年起。2013年至2015年，他担任产品运营执行副总裁，负责监督NetApp产品组合中技术战略以及产品和解决方案开发的各个方面。Kurian先生于2011年4月加入NetApp，担任存储解决方案集团高级副总裁，并于2011年12月被任命为Data ONTAP集团高级副总裁。在加入NetApp之前，从2002年到2011年，Kurian先生曾在思科担任多个职位，包括最近担任副总裁兼应用网络和交换技术集团总经理。1999年至2002年，Kurian先生在阿克迈担任产品管理和战略副总裁。在此之前，他是麦肯锡公司的管理顾问，并在甲骨文股份有限公司领导软件工程和产品管理团队。Kurian先生是全球健康服务公司信诺集团的董事会成员。
George Kurian is the Chief Executive Officer of NetApp, a position he has held since June 1, 2015. He joined Netapp, Inc.'s Board of Directors in June 2015. From September 2013 to May 2015, he was Executive Vice President of Product Operations, overseeing all aspects of technology strategy, product and solutions development across Netapp, Inc.'s portfolio. Mr. Kurian joined NetApp in April 2011 as the Senior Vice President of the Storage Solutions group and was appointed to Senior Vice President of the Data ONTAP group in December 2011. Prior to joining NetApp, Mr. Kurian held several positions with Cisco Systems from 2002 to 2011, including Vice President and General Manager of the Application Networking and Switching Technology group. Additional roles include Vice President of Product Management and Strategy at Akamai Technologies from 1999 to 2002, as well as a management consultant at McKinsey and Company and a leader on the software engineering and product management teams at Oracle Corporation. Mr. Kurian is a board member at Cigna Corporation, a global health services company, where he serves on the compliance committee and people resources committee, and holds a BS degree in electrical engineering from Princeton University and an MBA degree from Stanford University. - George Kurian，被任命为NetApp首席执行官，并一直担任董事会成员，自2015年起。2013年至2015年，他担任产品运营执行副总裁，负责监督NetApp产品组合中技术战略以及产品和解决方案开发的各个方面。Kurian先生于2011年4月加入NetApp，担任存储解决方案集团高级副总裁，并于2011年12月被任命为Data ONTAP集团高级副总裁。在加入NetApp之前，从2002年到2011年，Kurian先生曾在思科担任多个职位，包括最近担任副总裁兼应用网络和交换技术集团总经理。1999年至2002年，Kurian先生在阿克迈担任产品管理和战略副总裁。在此之前，他是麦肯锡公司的管理顾问，并在甲骨文股份有限公司领导软件工程和产品管理团队。Kurian先生是全球健康服务公司信诺集团的董事会成员。
- George Kurian is the Chief Executive Officer of NetApp, a position he has held since June 1, 2015. He joined Netapp, Inc.'s Board of Directors in June 2015. From September 2013 to May 2015, he was Executive Vice President of Product Operations, overseeing all aspects of technology strategy, product and solutions development across Netapp, Inc.'s portfolio. Mr. Kurian joined NetApp in April 2011 as the Senior Vice President of the Storage Solutions group and was appointed to Senior Vice President of the Data ONTAP group in December 2011. Prior to joining NetApp, Mr. Kurian held several positions with Cisco Systems from 2002 to 2011, including Vice President and General Manager of the Application Networking and Switching Technology group. Additional roles include Vice President of Product Management and Strategy at Akamai Technologies from 1999 to 2002, as well as a management consultant at McKinsey and Company and a leader on the software engineering and product management teams at Oracle Corporation. Mr. Kurian is a board member at Cigna Corporation, a global health services company, where he serves on the compliance committee and people resources committee, and holds a BS degree in electrical engineering from Princeton University and an MBA degree from Stanford University.
高管简历
中英对照 | 中文 | 英文- Brian C. Evanko
Brian C. Evanko，政府业务总裁，2017年11月开始； 2013年8月至2017年11月为美国个人业务总裁； 2012年9月至2013年8月，信诺全球个人健康，生命和事故业务财务总监； 2008年12月至2012年9月，信诺全球，健康，生命和事故个人首席精算师。
Brian C. Evanko was appointed Chief Executive Officer of the Company, effective July 1, 2026. He currently serves as President and Chief Operating Officer of The Cigna Group, a role he has held since March 2025. He served as Executive Vice President, Chief Financial Officer of The Cigna Group and President and Chief Executive Officer, Cigna Healthcare from January 2024 through March 2025; Executive Vice President and Chief Financial Officer of The Cigna Group from January 2021 to January 2024; President, Government Biness from November 2017 to January 2021; and President, U.S. Individual Biness from August 2013 to November 2017. Over the cse of his nearly 30 year career with The Cigna Group, Mr. Evanko has led significant biness and functional areas. Mr. Evanko has delivered strong financial and operational results and led significant change through dynamic periods with his purpose driven, performance focused leadership.Mr. Evanko played a pivotal role in shaping the Company's strategic direction, driving priorities that are further strengthening ctomer affordability, access, and experience including the Company's "Commitments to Better." Mr. Evanko has a bachelor's degree in actuarial science from Pennsylvania State University and holds the FSA (Fellow of the Society of Actuaries), MAAA (Member of the American Academy of Actuaries) and CFA (Chartered Financial Analyst) designations.In addition to his responsibilities at The Cigna Group, Mr. Evanko serves on the board of directors for TriNet, a leading provider of comprehensive human resces solutions for small and medium size binesses, as ll as The Connecticut Science Center, the state's foremost institution for science education.BS, Pennsylvania State University.- Brian C. Evanko，政府业务总裁，2017年11月开始； 2013年8月至2017年11月为美国个人业务总裁； 2012年9月至2013年8月，信诺全球个人健康，生命和事故业务财务总监； 2008年12月至2012年9月，信诺全球，健康，生命和事故个人首席精算师。
- Brian C. Evanko was appointed Chief Executive Officer of the Company, effective July 1, 2026. He currently serves as President and Chief Operating Officer of The Cigna Group, a role he has held since March 2025. He served as Executive Vice President, Chief Financial Officer of The Cigna Group and President and Chief Executive Officer, Cigna Healthcare from January 2024 through March 2025; Executive Vice President and Chief Financial Officer of The Cigna Group from January 2021 to January 2024; President, Government Biness from November 2017 to January 2021; and President, U.S. Individual Biness from August 2013 to November 2017. Over the cse of his nearly 30 year career with The Cigna Group, Mr. Evanko has led significant biness and functional areas. Mr. Evanko has delivered strong financial and operational results and led significant change through dynamic periods with his purpose driven, performance focused leadership.Mr. Evanko played a pivotal role in shaping the Company's strategic direction, driving priorities that are further strengthening ctomer affordability, access, and experience including the Company's "Commitments to Better." Mr. Evanko has a bachelor's degree in actuarial science from Pennsylvania State University and holds the FSA (Fellow of the Society of Actuaries), MAAA (Member of the American Academy of Actuaries) and CFA (Chartered Financial Analyst) designations.In addition to his responsibilities at The Cigna Group, Mr. Evanko serves on the board of directors for TriNet, a leading provider of comprehensive human resces solutions for small and medium size binesses, as ll as The Connecticut Science Center, the state's foremost institution for science education.BS, Pennsylvania State University.
- Ann M. Dennison
Ann M. Dennison，自2024年1月起担任The Cigna Group的副首席财务官。此前，她从2021年3月起担任Nasdaq， Inc.的执行副总裁兼首席财务官；2015年4月至2021年3月担任纳斯达克高级副总裁、财务总监和首席会计官。
Ann M. Dennison Executive Vice President and Chief Financial Officer of The Cigna Group beginning March 2025; Deputy Corporate Financial Officer from January 2024 until March 2025. Executive Vice President and Chief Financial Officer of Nasdaq, Inc. from March 2021 until December 2023; Senior Vice President, Controller and Chief Accounting Officer from October 2015 until March 2021.- Ann M. Dennison，自2024年1月起担任The Cigna Group的副首席财务官。此前，她从2021年3月起担任Nasdaq， Inc.的执行副总裁兼首席财务官；2015年4月至2021年3月担任纳斯达克高级副总裁、财务总监和首席会计官。
- Ann M. Dennison Executive Vice President and Chief Financial Officer of The Cigna Group beginning March 2025; Deputy Corporate Financial Officer from January 2024 until March 2025. Executive Vice President and Chief Financial Officer of Nasdaq, Inc. from March 2021 until December 2023; Senior Vice President, Controller and Chief Accounting Officer from October 2015 until March 2021.
- Everett Neville
Everett Neville，2021年1月开始担任信诺保险集团公司执行副总裁，战略和业务发展；从2020年1月到2021年1月，负责价值创造和解决方案的高级副总裁；2018年12月至2020年1月任首席价值官；2018年1月至2018年12月担任Express Scripts战略、供应链和专业执行副总裁；2016年11月至2018年1月，担任战略、供应链和专业高级副总裁；2015年3月至2016年11月任供应链高级副总裁；2009年3月至2015年3月担任制药战略和合同副总裁。他于2015年3月被任命为快捷药方公司高级副总裁，负责供应链。加入Express Scripts公司之前，他曾担任多种临床职务，包括医院和护理管理，作为福利顾问、药剂师和药房董事。
Everett Neville Executive Vice President, Strategy and Biness Development beginning January 2021 Senior Vice President, Value Creation and Solutions from August 1998 until December 2020.- Everett Neville，2021年1月开始担任信诺保险集团公司执行副总裁，战略和业务发展；从2020年1月到2021年1月，负责价值创造和解决方案的高级副总裁；2018年12月至2020年1月任首席价值官；2018年1月至2018年12月担任Express Scripts战略、供应链和专业执行副总裁；2016年11月至2018年1月，担任战略、供应链和专业高级副总裁；2015年3月至2016年11月任供应链高级副总裁；2009年3月至2015年3月担任制药战略和合同副总裁。他于2015年3月被任命为快捷药方公司高级副总裁，负责供应链。加入Express Scripts公司之前，他曾担任多种临床职务，包括医院和护理管理，作为福利顾问、药剂师和药房董事。
- Everett Neville Executive Vice President, Strategy and Biness Development beginning January 2021 Senior Vice President, Value Creation and Solutions from August 1998 until December 2020.
- Jamie Kates
Jamie Kates自2021年10月起担任会计副总裁，据此她负责管理Evernorth Health Services的会计、合规和合并职能。在此之前，她曾于2019年1月至2021年10月担任会计部董事总经理，在此期间，她负责管理Evernorth Health Services的会计和合规职能。Kates女士于2009年加入信诺集团，在任职期间担任的职务越来越多。Kates女士是一名注册会计师。
Jamie Kates,has served as Vice President, Accounting, since October 2021, pursuant to which she managed the Evernorth Health Services accounting, compliance and consolidation functions. Prior to that, she served as Managing Director, Accounting, from January 2019 through October 2021, during which she managed the Evernorth Health Services accounting and compliance functions. Ms. Kates joined The Cigna Group in 2009 and has held roles of increasing responsibility during her tenure. Ms. Kates is a Certified Public Accountant.- Jamie Kates自2021年10月起担任会计副总裁，据此她负责管理Evernorth Health Services的会计、合规和合并职能。在此之前，她曾于2019年1月至2021年10月担任会计部董事总经理，在此期间，她负责管理Evernorth Health Services的会计和合规职能。Kates女士于2009年加入信诺集团，在任职期间担任的职务越来越多。Kates女士是一名注册会计师。
- Jamie Kates,has served as Vice President, Accounting, since October 2021, pursuant to which she managed the Evernorth Health Services accounting, compliance and consolidation functions. Prior to that, she served as Managing Director, Accounting, from January 2019 through October 2021, during which she managed the Evernorth Health Services accounting and compliance functions. Ms. Kates joined The Cigna Group in 2009 and has held roles of increasing responsibility during her tenure. Ms. Kates is a Certified Public Accountant.
- Durga Prasad Koka
Durga Prasad Koka于2025年9月开始担任信诺集团执行副总裁兼全球首席信息官；于2021年10月至2025年9月担任信息技术高级副总裁；于2020年5月至2021年5月担任希尔顿酒店企业解决方案和架构高级副总裁。
Durga Prasad Koka Executive Vice President and Global Chief Information Officer, The Cigna Group beginning September 2025; Senior Vice President, Information Technology from October 2021 until September 2025; SVP of Enterprise Solutions and Architecture, Hilton Worldwide from May 2020 until May 2021.- Durga Prasad Koka于2025年9月开始担任信诺集团执行副总裁兼全球首席信息官；于2021年10月至2025年9月担任信息技术高级副总裁；于2020年5月至2021年5月担任希尔顿酒店企业解决方案和架构高级副总裁。
- Durga Prasad Koka Executive Vice President and Global Chief Information Officer, The Cigna Group beginning September 2025; Senior Vice President, Information Technology from October 2021 until September 2025; SVP of Enterprise Solutions and Architecture, Hilton Worldwide from May 2020 until May 2021.
- David M. Cordani
David M. Cordani，于2022年1月被任命为董事会主席。自2009年起担任信诺集团首席执行官，自2008年起担任总裁。自1991年加入信诺集团以来，Cordani先生曾担任多个高级领导职务，包括首席运营官；信诺医疗保健总裁；客户细分和市场营销高级副总裁。在他任职期间，信诺集团已发展成为一家财富15强的全球健康公司，拥有大约1.89亿客户和患者关系，以及约72，500名员工。
David M. Cordani was appointed Chair of the Board in January 2022. He has served as the Chief Executive Officer of The Cigna Group since 2009 and President since 2008. Since joining The Cigna Group in 1991, Mr. Cordani has served in a number of senior leadership roles, including Chief Operating Officer; President, Cigna HealthCare; and Senior Vice President, Ctomer Segments and Marketing. Under his leadership, The Cigna Group has grown into a global health company with more than 185 million ctomer relationships and approximately 67,700 colleagues around the world.Mr. Cordani is active with a number of nonprofit organizations. He currently serves in vario capacities with the Achilles International Freedom Team of Wounded Veterans, among others, and oversees the David and Sherry Cordani Family Foundation, which was founded to support community health and overall ll being. Mr. Cordani has served as an Executive Committee member of America's Health Insurance Plans (AHIP) and previoly was appointed and served as Chair of the AHIP Board. With a commitment to international biness relations, Mr. Cordani also served as Chairman of the U.S. Chamber of Commerce's U.S. Korea Biness Council and on the U.S. India Biness Council Board of Directors.MBA, University of Hartford;BBA, Texas A&M University.- David M. Cordani，于2022年1月被任命为董事会主席。自2009年起担任信诺集团首席执行官，自2008年起担任总裁。自1991年加入信诺集团以来，Cordani先生曾担任多个高级领导职务，包括首席运营官；信诺医疗保健总裁；客户细分和市场营销高级副总裁。在他任职期间，信诺集团已发展成为一家财富15强的全球健康公司，拥有大约1.89亿客户和患者关系，以及约72，500名员工。
- David M. Cordani was appointed Chair of the Board in January 2022. He has served as the Chief Executive Officer of The Cigna Group since 2009 and President since 2008. Since joining The Cigna Group in 1991, Mr. Cordani has served in a number of senior leadership roles, including Chief Operating Officer; President, Cigna HealthCare; and Senior Vice President, Ctomer Segments and Marketing. Under his leadership, The Cigna Group has grown into a global health company with more than 185 million ctomer relationships and approximately 67,700 colleagues around the world.Mr. Cordani is active with a number of nonprofit organizations. He currently serves in vario capacities with the Achilles International Freedom Team of Wounded Veterans, among others, and oversees the David and Sherry Cordani Family Foundation, which was founded to support community health and overall ll being. Mr. Cordani has served as an Executive Committee member of America's Health Insurance Plans (AHIP) and previoly was appointed and served as Chair of the AHIP Board. With a commitment to international biness relations, Mr. Cordani also served as Chairman of the U.S. Chamber of Commerce's U.S. Korea Biness Council and on the U.S. India Biness Council Board of Directors.MBA, University of Hartford;BBA, Texas A&M University.
- Nicole S. Jones
Nicole S. Jones，2023年9月开始担任Cigna Group执行副总裁、首席行政官兼总法律顾问；2011年6月至2023年9月担任Cigna Group执行副总裁兼总法律顾问；2010年5月至2011年6月担任林肯金融集团高级副总裁兼总法律顾问；2008年4月至2010年5月担任信诺集团副总裁兼副总法律顾问；2006年9月至2010年4月担任公司秘书。
Nicole S. Jones Executive Vice President, Chief Administrative Officer and General Counsel for The Cigna Group beginning September 2023; Executive Vice President and General Counsel of The Cigna Group from June 2011 until September 2023; Senior Vice President and General Counsel of Lincoln Financial Group from May 2010 until June 2011; Vice President and Deputy General Counsel of The Cigna Group from April 2008 until May 2010; and Corporate Secretary from September 2006 until April 2010.- Nicole S. Jones，2023年9月开始担任Cigna Group执行副总裁、首席行政官兼总法律顾问；2011年6月至2023年9月担任Cigna Group执行副总裁兼总法律顾问；2010年5月至2011年6月担任林肯金融集团高级副总裁兼总法律顾问；2008年4月至2010年5月担任信诺集团副总裁兼副总法律顾问；2006年9月至2010年4月担任公司秘书。
- Nicole S. Jones Executive Vice President, Chief Administrative Officer and General Counsel for The Cigna Group beginning September 2023; Executive Vice President and General Counsel of The Cigna Group from June 2011 until September 2023; Senior Vice President and General Counsel of Lincoln Financial Group from May 2010 until June 2011; Vice President and Deputy General Counsel of The Cigna Group from April 2008 until May 2010; and Corporate Secretary from September 2006 until April 2010.